<scp>P</scp>ill<scp>C</scp>am colon capsule endoscopy <i>versus</i> conventional colonoscopy for the detection of severity and extent of ulcerative colitis

Ye, Chen An; Gao, Youguang; Ge, Zhi Zheng; Dai, Jun; Li, Xiao Bo; Xue, Hao; Ran, Zhi Hua; Zhao, Yun

doi:10.1111/1751-2980.12005

Cited by 53 publications

(46 citation statements)

References 51 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Small bowel patency capsule prior to capsule endoscopy, therefore, is not considered necessary in most CD patients. There is a strong correlation in severity and extent of disease between the colon capsule endoscopy and the conventional colonoscopy in patients with UC . However, colon capsule endoscopy may underestimate both severity and extent of disease .…”

Section: Resultsmentioning

confidence: 99%

Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn's disease in Asia

Ooi

Hilmi

Banerjee

et al. 2019

J of Gastro and Hepatol

Self Cite

View full text Add to dashboard Cite

The Asia–Pacific Working Group on Inflammatory Bowel Disease was established in Cebu, Philippines, under the auspices of the Asia–Pacific Association of Gastroenterology with the goal of improving inflammatory bowel disease care in Asia. This consensus is carried out in collaboration with Asian Organization for Crohn's and Colitis. With biologic agents and biosimilars becoming more established, it is necessary to conduct a review on existing literature and establish a consensus on when and how to introduce biologic agents and biosimilars in conjunction with conventional treatments for ulcerative colitis and Crohn's disease in Asia. These statements also address how pharmacogenetics influences the treatments of ulcerative colitis and Crohn's disease and provides guidance on response monitoring and strategies to restore loss of response. Finally, the review includes statements on how to manage treatment alongside possible hepatitis B and tuberculosis infections, both common in Asia. These statements have been prepared and voted upon by members of inflammatory bowel disease workgroup employing the modified Delphi process. These statements do not intend to be all‐encompassing, and future revisions are likely as new data continue to emerge.

show abstract

Section: Resultsmentioning

confidence: 99%

Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn's disease in Asia

Ooi

Hilmi

Banerjee

et al. 2019

J of Gastro and Hepatol

Self Cite

View full text Add to dashboard Cite

show abstract

“…Colon capsule endoscopy (CCE) was introduced in 2006 and has been used mainly for colorectal cancer screening . Since 2006, the feasibility of CCE for evaluating ulcerative colitis (UC) has been tested by several groups . The criteria for evaluation of UC are different from those for colorectal polyp/cancer screening because of differences in severity and extent of mucosal inflammation.…”

Section: Introductionmentioning

confidence: 99%

“…Thus, CCE may be advantageous because it may increase patient acceptance of the procedure. However, the applicability of CCE for evaluation of UC remains unconfirmed …”

Section: Introductionmentioning

confidence: 99%

Modified bowel preparation regimen for use in second‐generation colon capsule endoscopy in patients with ulcerative colitis

Usui

Hosoe

Matsuoka

et al. 2014

Digestive Endoscopy

View full text Add to dashboard Cite

show abstract

“…Recently, several studies on surveillance of inflammatory bowel diseases (IBD) have been published, mainly on ulcerative colitis (UC) [33][34][35][36][37]. However, data regarding use of CCE in patients with IBD are insufficient because histological verification is required for diagnosis of IBD.…”

Section: Cce In Ibdmentioning

confidence: 99%

Colon capsule endoscopy: toward the future

Muguruma

Tanaka

Teramae

et al. 2017

Clin J Gastroenterol

View full text Add to dashboard Cite

Colon capsule endoscopy is a wireless and minimally invasive technique for visualization of the whole colon. With recent improvements of technical features in second-generation systems, a more important role for colon capsule endoscopy is rapidly emerging. Although several limitations and drawbacks are yet to be resolved, its usefulness as a tool for colorectal cancer screening and monitoring disease activity in inflammatory bowel diseases has become more apparent with increased use. Further investigations, including multicenter trials, are required to evaluate the substantial role of the colon capsule in managing colorectal diseases.

show abstract

PillCam colon capsule endoscopy versus conventional colonoscopy for the detection of severity and extent of ulcerative colitis

Abstract: PCCE provides an outstanding performance in the detection of the severity and extent of active UC.

Cited by 53 publications

References 51 publications

Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn's disease in Asia

Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn's disease in Asia

Modified bowel preparation regimen for use in second‐generation colon capsule endoscopy in patients with ulcerative colitis

Colon capsule endoscopy: toward the future

Contact Info

Product

Resources

About